<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>7027374</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">32116776</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">7027374</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.3389/fphys.2020.00066</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Demographic characteristics and rating of symptoms for the analyzed subjects.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1</label><caption><p>Demographic characteristics and rating of symptoms for the analyzed subjects.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>CTR</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>BS</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>UHR</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Statistical evaluation</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>N</italic></td><td valign="top" align="center" rowspan="1" colspan="1">29</td><td valign="top" align="center" rowspan="1" colspan="1">25</td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Gender (f:m)</td><td valign="top" align="center" rowspan="1" colspan="1">13:16</td><td valign="top" align="center" rowspan="1" colspan="1">8:17</td><td valign="top" align="center" rowspan="1" colspan="1">9:9</td><td valign="top" align="left" rowspan="1" colspan="1">χ<sup>2</sup> = 1.6, <italic>n</italic>.<italic>s</italic>.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Handedness (r:l:b)</td><td valign="top" align="center" rowspan="1" colspan="1">25:2:2</td><td valign="top" align="center" rowspan="1" colspan="1">22:1:2</td><td valign="top" align="center" rowspan="1" colspan="1">17:1:0</td><td valign="top" align="left" rowspan="1" colspan="1">χ<sup>2</sup> = 1.7, <italic>n</italic>.<italic>s</italic>.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (years)</td><td valign="top" align="center" rowspan="1" colspan="1">22.8 ± 5.0</td><td valign="top" align="center" rowspan="1" colspan="1">21.0 ± 4.5</td><td valign="top" align="center" rowspan="1" colspan="1">20.8 ± 4.1</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>F</italic> = 1.6, <italic>n</italic>.<italic>s</italic>.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Estimated intelligence</td><td valign="top" align="center" rowspan="1" colspan="1">111.7 ± 14.5</td><td valign="top" align="center" rowspan="1" colspan="1">101.0 ± 11.6</td><td valign="top" align="center" rowspan="1" colspan="1">95.0 ± 7.1</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>F</italic> = 0.9, <italic>n</italic>.<italic>s</italic>.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SIPS (Positive)</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">4.7 ± 2.8</td><td valign="top" align="center" rowspan="1" colspan="1">9.0 ± 4.3</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>U</italic> = −3.4, <italic>p</italic> &lt; 0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SIPS (Negative)</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">7.8 ± 4.6</td><td valign="top" align="center" rowspan="1" colspan="1">11.9 ± 5.7</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>U</italic> = −2.4, <italic>p</italic> = 0.1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SIPS (General)</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">6.2 ± 2.8</td><td valign="top" align="center" rowspan="1" colspan="1">7.5 ± 3.9</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>U</italic> = −1.5, <italic>n</italic>.<italic>s</italic>.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SIPS (Disorganization)</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">2.8 ± 2.1</td><td valign="top" align="center" rowspan="1" colspan="1">4.4 ± 2.0</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>U</italic> = −2.9, <italic>p</italic> = 0.004</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GAF</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">64.7 ± 12.9</td><td valign="top" align="center" rowspan="1" colspan="1">59.8 ± 11.9</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>U</italic> = −1.1, <italic>n</italic>.<italic>s</italic>.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CPZ equivalents</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">18.00 ± 51.5</td><td valign="top" align="center" rowspan="1" colspan="1">118.3 ± 490</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>T</italic> = 1.2, <italic>n</italic>.<italic>s</italic>.</td></tr></tbody></table><table-wrap-foot><p><italic>The 29 healthy controls (CTR), 25 subjects with basic symptoms of psychosis (BS), and 18 subjects at ultra-high risk for psychosis (UHR) considered in this study are matched for gender balance and handedness, as assessed by Pearson's χ<sup>2</sup> test. They are also matched for age and estimated intelligence, as determined with a three-level analysis of variance test. The extent of symptoms according to the Structured Interview for Prodromal Syndromes (SIPS), and the Global Assessment of Functioning (GAF) scale mean, are also provided for BS and UHR subjects, who are compared by a Mann–Whitney U-test. Finally, chlorpromazine (CPZ) equivalents are also shown, contrasting both groups with a t-test. Data is presented as mean ± standard deviation where appropriate</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic characteristics and rating of symptoms for the analyzed subjects.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th valign="top" align="center">CTR</th><th valign="top" align="center">BS</th><th valign="top" align="center">UHR</th><th valign="top" align="left">Statistical evaluation</th></tr></thead><tbody><tr><td valign="top" align="left">N</td><td valign="top" align="center">29</td><td valign="top" align="center">25</td><td valign="top" align="center">18</td><td/></tr><tr><td valign="top" align="left">Gender (f:m)</td><td valign="top" align="center">13:16</td><td valign="top" align="center">8:17</td><td valign="top" align="center">9:9</td><td valign="top" align="left">χ2 = 1.6, n.s.</td></tr><tr><td valign="top" align="left">Handedness (r:l:b)</td><td valign="top" align="center">25:2:2</td><td valign="top" align="center">22:1:2</td><td valign="top" align="center">17:1:0</td><td valign="top" align="left">χ2 = 1.7, n.s.</td></tr><tr><td valign="top" align="left">Age (years)</td><td valign="top" align="center">22.8 ± 5.0</td><td valign="top" align="center">21.0 ± 4.5</td><td valign="top" align="center">20.8 ± 4.1</td><td valign="top" align="left">F = 1.6, n.s.</td></tr><tr><td valign="top" align="left">Estimated intelligence</td><td valign="top" align="center">111.7 ± 14.5</td><td valign="top" align="center">101.0 ± 11.6</td><td valign="top" align="center">95.0 ± 7.1</td><td valign="top" align="left">F = 0.9, n.s.</td></tr><tr><td valign="top" align="left">SIPS (Positive)</td><td valign="top" align="center">–</td><td valign="top" align="center">4.7 ± 2.8</td><td valign="top" align="center">9.0 ± 4.3</td><td valign="top" align="left">U = −3.4, p &lt; 0.001</td></tr><tr><td valign="top" align="left">SIPS (Negative)</td><td valign="top" align="center">–</td><td valign="top" align="center">7.8 ± 4.6</td><td valign="top" align="center">11.9 ± 5.7</td><td valign="top" align="left">U = −2.4, p = 0.1</td></tr><tr><td valign="top" align="left">SIPS (General)</td><td valign="top" align="center">–</td><td valign="top" align="center">6.2 ± 2.8</td><td valign="top" align="center">7.5 ± 3.9</td><td valign="top" align="left">U = −1.5, n.s.</td></tr><tr><td valign="top" align="left">SIPS (Disorganization)</td><td valign="top" align="center">–</td><td valign="top" align="center">2.8 ± 2.1</td><td valign="top" align="center">4.4 ± 2.0</td><td valign="top" align="left">U = −2.9, p = 0.004</td></tr><tr><td valign="top" align="left">GAF</td><td valign="top" align="center">–</td><td valign="top" align="center">64.7 ± 12.9</td><td valign="top" align="center">59.8 ± 11.9</td><td valign="top" align="left">U = −1.1, n.s.</td></tr><tr><td valign="top" align="left">CPZ equivalents</td><td valign="top" align="center">–</td><td valign="top" align="center">18.00 ± 51.5</td><td valign="top" align="center">118.3 ± 490</td><td valign="top" align="left">T = 1.2, n.s.</td></tr></tbody></table></div>The 29 healthy controls (CTR), 25 subjects with basic symptoms of psychosis (BS), and 18 subjects at ultra-high risk for psychosis (UHR) considered in this study are matched for gender balance and handedness, as assessed by Pearson's χ2 test. They are also matched for age and estimated intelligence, as determined with a three-level analysis of variance test. The extent of symptoms according to the Structured Interview for Prodromal Syndromes (SIPS), and the Global Assessment of Functioning (GAF) scale mean, are also provided for BS and UHR subjects, who are compared by a Mann–Whitney U-test. Finally, chlorpromazine (CPZ) equivalents are also shown, contrasting both groups with a t-test. Data is presented as mean ± standard deviation where appropriate.</transformed-table></extracted-table></extracted-tables-set>